We have investigated the role of iron in the intracellular biology of Legionella pneumophila in human monocytes and in the effector arm of cell-mediated immune defense against this intracellular bacterial pathogen. By Scatchard analysis of '251-transferrin binding to monocytes, nonactivated monocytes had 38,300±12,700 (mean±SE) transferrin binding sites, whereas activated monocytes had 10,300±1,600, a reduction of 73%. Activated and nonactivated monocytes had a similar mean Kd (1.8±0.2 nM).
Introduction
We have investigated the role of iron in the intracellular biology of Legionella pneumophila in human monocytes and in the effector arm of cell-mediated immune defense against this intracellular bacterial pathogen.
To determine if L. pneumophila intracellular multiplication is iron dependent, we studied the effect of the iron chelator deferoxamine on L. pneumophila infection of monocytes. Deferoxamine at 15 gM completely inhibited L. pneumophila intracellular multiplication. The inhibitory effect of deferoxamine was reversed with equimolar iron-saturated transferrin but not apotransferrin.
To examine the potential role of iron in monocyte activation, we investigated the influence of iron-saturated transferrin on L. pneumophila multiplication in IFNy-activated monocytes. Iron transferrin, but not apotransferrin, neutralized the capacity of activated monocytes to inhibit L. pneumophila multiplication.
To explore a potential mechanism by which activated monocytes might limit the availability of intracellular iron, we examined transferrin receptor expression on nonactivated and activated monocytes cultured in vitro for 5 d. By fluorescenceactivated flow cytometry, activated monocytes exhibited markedly fewer transferrin receptors than nonactivated monocytes.
Legionella pneumophila is a facultative, gram-negative, intracellular bacterial pathogen that invades the lung and parasitizes alveolar macrophages (1) (2) (3) . Cell-mediated immunity appears to play a major role in host defense against L. pneumophila (4) . Human monocytes and alveolar macrophages activated by cytokines from mitogen-or antigen-stimulated lymphocytes, or by recombinant human IFNy, inhibit L. pneumophila intracellular multiplication (4) (5) (6) (7) (8) . Although activated mononuclear phagocytes inhibit the multiplication of L. pneumophila, they do not kill the intracellular bacteria (2, 5, 6) . This suggests that the major contribution of cell-mediated immunity to host defense against L. pneumophila is to inhibit bacterial multiplication rather than kill the pathogen.
The mechanisms by which activated macrophages exert an antimicrobial effect are incompletely understood. In this paper we shall propose that activated human monocytes inhibit L. pneumophila intracellular multiplication by limiting the availability of iron.
L. pneumophila has a definite metabolic requirement for iron, reflected by an inability to grow on agar medium in the absence of iron supplementation (9) or in broth medium to which iron chelators, including apotransferrin, enterochelin, or deferoxamine, have been added (10, 1 1). Unlike most gram-negative bacteria, L. pneumophila does not produce siderophores, soluble iron-chelating compounds, that would allow it to remove iron in vivo from high affinity iron-binding compounds such as transferrin (1 1). L. pneumophila multiplication is thus restricted to environments in which iron is readily available and not bound to high affinity iron-binding compounds. The distinctive ribosome-lined phagosome in which L. pneumophila multiplies intracellularly is presumably one such environment in mononuclear phagocytes (12) .
Mononuclear phagocytes, like other mammalian cells, acquire iron via transferrin receptors on their surface (13, 14) . The transferrin receptor is thought to be composed of two identical polypeptide chains, each capable of binding a diferric transferrin molecule at neutral pH (15) . The transferrin receptor-transferrin complex is endocytized, after which the endocytic vacuole is acidified. As the pH decreases, ferric ions dissociate from transferrin and are distributed intracellularly. The apotransferrin remains bound to the transferrin receptor until the receptor recycles to the cell surface, whereupon apotransferrin dissociates from the receptor (16) . The internalized iron enters the so-called labile iron pool of the cell ( 17) .
In this study we 
Methods
Media. Egg yolk buffer with of without 1% BSA, and PBS were prepared or obtained as described (1) . RPMI 1640 medium with L-glutamine (RPMI)' (Gibco Laboratories, Grand Island, NY) was used alone, with 10 mM Hepes buffer (Sigma Chemical Co., St. Louis, MO), or with 10 mM Hepes buffer and 0.1% BSA (Sigma Chemical Co.). Antibiotics were not added to media in any experiment.
Tissue culture reagents. Deferoxamine mesylate (Ciba-Geigy, Summit, NJ), iron-saturated transferrin, and apotransferrin (Miles Scientific, Kanakee, IL) were dissolved in RPMI and filtered through 0. 22 Agar. Modified charcoal yeast extract agar was prepared in 100 X 15-mm bacteriologic petri dishes as described (1) .
Serum. Venous blood was obtained from healthy, adult volunteers with no history of Legionnaires' disease, and serum was separated and stored at -70'C. In all experiments autologous serum was used.
Bacteria. L. pneumophila, Philadelphia 1 strain, serogroup 1, was grown in embryonated hens' eggs, harvested, tested for viability and for the presence of contaminating bacteria, and stored at -70°C as described (1). In some experiments bacteria were partially purified by differential centrifugation just before use. In most experiments the bacteria were passed one time only on modified charcoal yeast extract agar for 80 h, harvested, stored at -70°, and thawed in a 37°C waterbath just before use.
Human blood mononuclear cells. Mononuclear cells used in all experiments were obtained from the blood ofhealthy, adult volunteers with no history of Legionnaires' disease. The blood mononuclear cell fraction was obtained by centrifugation over a Ficoll-sodium diatrizoate solution (Pharmacia Fine Chemicals, Piscataway, NJ) as previously described (1) . For some experiments, monocyte-and lymphocyte-enriched populations ofcells were obtained from the blood mononuclear cell fraction on preformed Percoll gradients as described (18) .
Assay for iron dependence ofL. pneumophila intracellular multiplication in monocytes. Freshly explanted monocytes were adhered to Linbro flat-bottomed wells (16 mm in diameter; Flow Laboratories, Inc., McLean, VA) as described (4) . The monocyte monolayers containing -5 X 105 cells were then incubated at 37°C in 5% C02-95% air in 0.5 ml of RPMI containing 20% fresh normal human serum and either deferoxamine mesylate at a final concentration of 15, 25, or 35 MM, or control medium. In some experiments iron transferrin (7.5 AM) or apotransferrin (7.5 gM) was added to wells containing deferoxamine. After 24 h L. pneumophila (5 X 102 CFU/ml) were added to the monocytes, and the cultures were incubated at 37°C in 5% C02-95% air on a gyratory shaker (100 rpm) for 1 h and under stationary conditions thereafter. CFUI ofL. pneumophila in each culture were determined daily as described (1) . After 96 h, the viability of monocytes was assayed by trypan blue exclusion. All experiments were run in triplicate. to allow the release of previously bound transferrin from transferrin receptors and to allow internalized, functional transferrin receptors to recycle back to the cell surface so that these receptors would be available for binding '25I-transferrin in this assay. After the preincubation, 5 ml of RPMI-10 mM Hepes-0. 1% BSA at 4VC was immediately added to each tube, and the cells were centrifuged at 150 g for 10 min. The supernatant fluid was removed and '25I-diferric transferrin (New England Nuclear, Boston, MA) was added to each triplicate tube. Specific activity of the preparation of '251I-transferrin used ranged from 0.5 to 0.8 MCi/Pg. Unlabeled iron transferrin was added to one tube of each triplicate set at a final concentration of 10,000 nM to control for nonspecific binding. Six sets of triplicate tubes were prepared in this way with concentrations of '251-transferrin ranging from 0.1 to 6 nM.
The tubes were gassed with C02, capped, and sealed with parafilm. After a 3-h incubation period at 4VC the monocytes were washed twice with 4-6 ml ofRPMI-10 mM Hepes-0. 1% BSA, suspended in 1 ml of 1 N NaOH, transferred to 12 X 75-mm polystyrene tubes (Falcon 2054; Becton Dickinson), and '251-transferrin bound was counted on a gamma counter with a counting efficiency of 68% for 1251 (Beckman Biogamma II; Beckman Instruments, Inc., Fullerton, CA).
In experiments in which the binding of '251-transferrin to nonactivated monocytes and nonactivated lymphocytes was compared, lymphocyte-enriched cell suspensions were cultured in Teflon wells as described above. After 5 d the lymphocytes were incubated twice, sequentially, in 35-mm plastic tissue culture dishes (Falcon 3001; Becton Dickinson) at 37°C for 90 min in 5% C02-95% air to allow any remaining monocytes to adhere. A sample from the purified lymphocyte preparation was then centrifuged onto a glass slide with a cytocentrifuge and stained with alpha naphthyl acetate esterase stain, and the percentage of lymphocytes in this final preparation was determined. The lymphocytes were then used in the assay described above.
In some experiments the step involving culture ofthe monocytes in Teflon wells was eliminated. In these experiments, freshly isolated monocyte-enriched cell suspensions were added directly to 17 X 100-mm polypropylene tubes and incubated in RPMI containing 20% autologous serum in the presence or absence of IFN for 5 d at 37°C in 5% C02-95% air. The monocytes were then washed twice to remove serum, resuspended in 500 ,l of RPMI-10 mM Hepes, and preincubated at 37°C for 90 min in 5% C02-95% air. The remaining part ofthe assay was the same as described above.
Results
L. pneumophila intracellular multiplication is iron dependent. To determine ifL. pneumophila requires access to intracellular iron to multiply, we examined the influence of the iron chelator deferoxamine on L. pneumophila intracellular multiplication. Deferoxamine chelates iron in what has been characterized as the labile iron pool (17, (19) (20) (21) . We infected monocytes with L. pneumophila in the presence or absence of deferoxamine and assayed intracellular multiplication (Fig. 1 To confirm that the effect of deferoxamine resulted from its capacity to chelate iron, we added 7.5 MM iron-saturated transferrin (equimolar for iron-binding capacity with deferoxamine) to monocyte cultures treated with 15 MM deferoxamine (Fig. 2) . Under physiologic conditions, deferoxamine does not remove appreciable amounts of iron from transferrin (22) . We added apotransferrin (99% unsaturated) to control cultures.
Iron transferrin completely reversed the capacity of deferoxamine to inhibit L. pneumophila multiplication (Fig. 2) . In the presence of both deferoxamine and iron-saturated transferrin, L. pneumophila multiplied to the same extent as in untreated control cultures. In contrast, apotransferrin (7.5 MM) had only a minimal effect on deferoxamine-treated monocytes.
Thus, L. pneumophila multiplication in monocytes is dependent upon the availability of intracellular iron.
The capacity ofactivated monocytes to inhibit L. pneumophila multiplication is reversed by iron transferrin. We then hypothesized that iron may play an important role in monocyte activation against L. pneumophila. To explore this, we studied the influence of iron transferrin on L. pneumophila multiplication in IFNy-activated monocytes (Fig. 3 medium, iron-saturated transferrin (6 mg/ml), or apotransferrin (6 mg/ml). After 24 h all cultures were infected with L. pneumophila. CFU of L. pneumophila were determined daily. Data are mean±SEM for triplicate cultures.
Iron transferrin at a concentration of 6 mg/ml, approximately twice the concentration in normal human serum, completely reversed the capacity of IFN'y-activated monocytes to inhibit L. pneumophila multiplication. In contrast, apotransferrin at a concentration of 6 mg/ml had only a minimal effect on L. pneumophila multiplication in activated monocytes.
The neutralizing effect of iron transferrin on monocyte activation was dose dependent (Fig. 4) . At a concentration of 6 mg/ml, iron transferrin completely reversed the capacity of IFN'y-activated monocytes to inhibit L. pneumophila multiplication. At concentrations of 2.0 and 0.7 mg/ml, iron transferrin partially reversed monocyte activation. At concentrations of0.2 mg/ml or less, iron transferrin had little or no effect on the capacity of activated monocytes to inhibit L. pneumophila multiplication.
These experiments indicated that IFNy-activated monocytes inhibit L. pneumophila intracellular multiplication by limiting the availability of intracellular iron.
Transferrin receptors are downregulated on IFNy-activated monocytes. We hypothesized that one way that activated monocytes might limit the availability of intracellular iron is In two experiments on one subject (subject 3 in Table I , see below) we generated histograms of monocytes treated with anti-transferrin receptor MAb and control monocytes treated with an isotypic control MAb and determined the shift in mean peak fluorescent channel (MPFC) between the two histograms. In both experiments activated monocytes exhibited a markedly decreased shift in MPFC consistent with decreased transferrin receptor expression (Fig. 5) To assess specificity of 1251-transferrin binding, we incubated monocytes with a constant amount of 125I-transferrin and increasing amounts of unlabeled transferrin (Fig. 7) . For both activated and nonactivated monocytes, the amount of cell-bound 1251-transferrin decreased with increasing concentration of unlabeled transferrin, indicating that the binding of transferrin to the monocytes was specific.
To assess receptor number and affinity by Scatchard analysis, we incubated activated and nonactivated monocytes with various concentrations of '25I-transferrin for 3 h and measured the amount of transferrin bound to the cells (Fig. 8) . Preliminary experiments showed that specific binding to activated and nonactivated monocytes reached a plateau at 6 nM transferrin (i.e., transferrin binding was the same at 6 and 12 nM transferrin, indicating that the transferrin receptors were saturable). Therefore, in subsequent experiments, including the one shown in Fig. 8 , binding was measured at concentrations of transferrin up to 6 nM. Scatchard analysis of this equilibrium binding data revealed a single class of high affinity receptors on both activated and nonactivated monocytes (Fig. 9) .
The receptors on both types of monocytes had a similar Kd, but activated monocytes had fewer receptors. The Kd of transferrin receptors of monocytes showed relatively little variation among subjects. The mean Kd was 1.84±0.24 nM for nonactivated monocytes and was not significantly different for activated monocytes.
To assess the potential influence of transferrin receptors from contaminating lymphocytes on the results of this assay, we performed Scatchard analysis on a purified population (99.9%) of 5-d-old lymphocytes and on 5-d-old monocytes from the same individual at the same time. The lymphocytes had < 400 transferrin binding sites per cell, compared with 21,600 per monocyte. Thus, the contribution of transferrin receptors from contaminating lymphocytes was minimal in this assay.
Since monocytes cultured in Teflon wells for 5 d adhere to some extent, we wanted to insure that our results showing transferrin receptor downregulation on IFNy-activated monocytes relative to nonactivated monocytes were representative of the total monocyte population cultured, and not influenced by selection of an unrepresentative, less adherent monocyte population. To study a wholly unselected population ofmonocytes, we eliminated the step that required harvesting adherent cells from Teflon wells. Instead, we added monocyte-enriched suspensions directly to the assay tubes and incubated them for 5 d in these tubes before performing the assay. We performed this assay on subjects 2, 3, and 4. Scatchard analysis revealed similar relative numbers oftransferrin receptors on monocytes of the three subjects, as was observed with the initial assay (subject 2 > subject 3 > subject 4). The percent decrease in transferrin receptor number with IFN activation was also similar to that observed in the initial assay. Subject 2 had a 79% decrease in transferrin receptor number on activated monocytes, subject 3 had a 49% decrease, and subject 4 had a 38% decrease. Thus, the monocytes cultured in Teflon wells and then examined in the initial assay were representative of the originally isolated monocyte population.
Discussion
Our study demonstrates that L. pneumophila intracellular multiplication is iron dependent. Deferoxamine inhibits L. pneumophila intracellular multiplication and iron transferrin reverses this inhibition. Deferoxamine chelates iron in the socalled labile iron pool. This pool consists of iron that is immediately available to the cell for metabolic processes ( 17) . Such iron is in a readily transportable form rather than in storage compounds such as ferritin or hemosiderin (17, (19) (20) (21) . Iron released from endocytized iron transferrin immediately enters this pool before it is used for metabolic processes or bound to ferritin (17) . Deferoxamine does not chelate a significant amount of iron bound to transferrin under physiologic conditions (22) , nor does it evidently remove iron directly from ferritin (17) . That deferoxamine inhibits L. pneumophila multiplication therefore indicates that L. pneumophila derives its iron from the labile iron pool.
After phagocytosis, L. pneumophila resides in a phagosome that interacts sequentially with monocyte smooth vesicles, mitochondria, and ribosomes, a process culminating in the formation of a ribosome-lined replicative phagosome (12) . This phagosome does not fuse with lysosomes (24) , and it has a pH of -6.1 (25) . After endocytosis, transferrin segregates to a juxtanuclear, para-Golgi compartment (26, 27) with approximately the same pH as the L. pneumophila phagosome (27) . It is possible that the L. pneumophila phagosome is in contiguity with the intracellular compartment through which iron transferrin passes. If so, then L. pneumophila would have access to iron as it dissociates from transferrin. Alternatively, L. pneumophila may acquire iron at some point subsequent to the release of iron from transferrin. The immediate fate of iron that dissociates from transferrin is not known. It is presumably transported to its various destinations in the cell by an as yet uncharacterized intracellular shuttle system. L. pneumophila multiplies exclusively intracellularly under tissue culture conditions, and probably also in nature. Our study indicates that, intracellularly, L. pneumophila has access to the labile iron pool. The bacterium may thus have no need for siderophores to remove iron from iron transferrin or other iron-binding compounds in the extracellular environment. Thus, it is perhaps not surprising that L. pneumophila does not produce siderophores or possess receptors for any of the known types of iron-chelating siderophores that promote extracellular iron acquisition by bacteria (1 1).
Deferoxamine has been shown to inhibit the intracellular multiplication of other parasites including Trypanosoma cruzi, which, like L. pneumophila, is an intracellular parasite of mononuclear phagocytes. Deferoxamine inhibited the multiplication of T. cruzi amastigotes without inducing toxic effects in mouse peritoneal macrophages at concentrations of 17 and 33 ,uM, a range similar to that used in our study (28) . Deferoxamine has also been found to inhibit the multiplication of Plasmodiumfalciparum in human erythrocytes at concentrations as low as 15 ,M (29). Interestingly, in studies ofthe effect of deferoxamine on Plasmodium berghei infection in rats, the size of the labile iron pool in the reticulocyte has been found to be relatively stable irrespective of host iron status (21) . This suggests that host iron status may be relatively un-important in infection of reticulocytes by the malaria parasite and, by analogy, in infection of mononuclear phagocytes by other intracellular pathogens such as L. pneumophila. Thus, exogenous factors such as deferoxamine, or endogenous factors such as IFNy, which act to modify the size of the labile iron pool or the availability of intracellular iron, may be a more important influence on the course of intracellular infection than total body iron stores.
Our study demonstrates that iron transferrin, at a concentration approximately twice that in serum, completely reverses the capacity of IFNy-activated monocytes to inhibit L. pneumophila multiplication. Apotransferrin is unable to reverse the inhibitory effect of activation. The most likely explanation for the effect of iron transferrin is that it overcomes a limitation in intracellular iron availability imposed on L. pneumophila by the activated monocyte. The effect ofiron transferrin is probably not due to a toxic effect on monocytes for several reasons. First, monocytes treated with iron transferrin were viable and did not exhibit morphologic signs of toxicity. Second, the reversal of activation by transferrin was reflected by multiplication of L. pneumophila, which requires live, metabolically intact monocytes to replicate (1) . Third, lower concentrations of iron transferrin, 0.7 and 2.0 mg/ml, in the physiologic range, partially reversed the inhibitory effect of activation.
The effect of iron transferrin is also probably not due to impairment of oxidative killing mechanisms of the activated macrophage for several reasons. First, iron plays a role in the generation of toxic oxidative metabolites associated with the respiratory burst. Specifically, in the Fenton reaction, ferric iron reacts with hydrogen peroxide to produce hydroxyl radical (30, 31) . In vitro, under cell-free conditions, hydroxyl radical is one of the most active oxidative metabolites against L. pneumophila (32) . Were iron derived from iron transferrin influencing this system in monocytes, it should if anything reduce L. pneumophila viability from increased generation of hydroxyl radical. Instead, iron transferrin promotes L. pneumophila multiplication. Second, oxidative metabolites exert a cidal effect on microorganisms. This is inconsistent with the antimicrobial effect of activated mononuclear phagocytes on L. pneumophila. Activated monocytes and alveolar macrophages inhibit L. pneumophila multiplication but do not kill the bacteria (2, 5, 6 (46) , a human uroepithelial cell line (47) , and human PBMC (48) , that catalyzes the breakdown of tryptophan. Consequently, IFN-y-activated fibroblasts and uroepithelial cells are thought to inhibit the multiplication of T. gondii and C. psittaci, respectively, by nutritionally depriving these organisms of tryptophan (46, 47) . However, the role of tryptophan deprivation in the microbial activity of human mononuclear phagocytes is questionable. In mononuclear phagocytes, IFN alpha and beta induce indoleamine 2,3-dioxygenase activity comparable to that of IFNy, but unlike IFNy these IFNs do not induce appreciable antitoxoplasma activity (49, 50) . Moreover, the addition of tryptophan to the media of IFN'y-activated monocytes does not reverse their antitoxoplasma activity (50, 51); nor does actinomycin D-induced blockade of tryptophan degradation (51). Thus, tryptophan degradation may not be in the repertoire of mechanisms by which activated mononuclear phagocytes exert an antimicrobial effect.
As a first step toward understanding the mechanism by which activated monocytes limit iron availability, we studied the effect of activation on transferrin receptor expression. Both human monocytes and alveolar macrophages, the host cells for L. pneumophila in the lung, express transferrin receptors. In a study by Hirata et al., human alveolar macrophages obtained by bronchoalveolar lavage expressed 64,000-112,000 transferrin binding sites/cell (32,000-56,000 transferrin receptors/cell) with an affinity constant (Ka) of 4.5 X 108 M-I (13). In nonactivated human monocytes, transferrin receptor expression increases with maturation. In the study by Hirata et al., freshly explanted human monocytes expressed no detectable transferrin receptors, whereas monocytes from one subject cultured in vitro for 14 d expressed 72,000 transferrin binding sites/cell (36, In conclusion, our study strongly supports the hypothesis that activated monocytes inhibit L. pneumophila intracellular multiplication by limiting the availability of intracellular iron. It seems likely that activated mononuclear phagocytes possess a repertoire of antimicrobial mechanisms. The one most effective against a particular pathogen may reflect the pathogen's individual nutritional and physiologic requirements and the pathogen's complement of innate defenses against oxidative metabolites (e.g., catalase, superoxide dismutase, glutathione peroxidase, glutathione reductase, and glutathione) and nonoxidative antimicrobial substances.
